Patents by Inventor Jamie Joseph FARRAR

Jamie Joseph FARRAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage forms comprising a plasma kallikrein inhibitor
    Patent number: 11234939
    Abstract: The present invention relates to oral solid dosage forms comprising a plasma kallikrein inhibitor, in particular a solid form (Form 1) of the compound of Formula A. Also provided are methods of preparing oral solid dosage forms comprising the compound of Formula A using Form 1 of the compound of Formula A.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: February 1, 2022
    Assignee: KalVista Pharmaceuticals Limited
    Inventors: John Herman Collett, Gary Paul Cook, Jamie Joseph Farrar, Michael John Frodsham, Michael Bryan Roe, Richard Simon Todd, Robert Neil Ward
  • DOSAGE FORMS COMPRISING A PLASMA KALLIKREIN INHIBITOR
    Publication number: 20200345647
    Abstract: The present invention relates to oral solid dosage forms comprising a plasma kallikrein inhibitor, in particular a solid form (Form 1) of the compound of Formula A. Also provided are methods of preparing oral solid dosage forms comprising the compound of Formula A using Form 1 of the compound of Formula A.
    Type: Application
    Filed: November 28, 2018
    Publication date: November 5, 2020
    Inventors: John Herman COLLETT, Gary Paul COOK, Jamie Joseph FARRAR, Michael John FRODSHAM, Michael Bryan ROE, Richard Simon TODD, Robert Neil WARD